| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdb1196d415d376ac56b76a956e20b47 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2011-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ec11c8783d3269118e8f9cd897563b |
| publicationDate |
2011-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TR-201104108-A2 |
| titleOfInvention |
Prolonged release memantine tablets. |
| abstract |
The present invention relates to an extended-release pharmaceutical composition comprising memantine hydrochloride. The composition is of the matrix type and comprises polyethylene oxide as the release controlling polymer. |
| priorityDate |
2011-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |